TREA

13,14-Didehydro-11-deoxy-17-phenyl-18,19,20-trinor-PGF.sub.1 .alpha. compounds

Follow

Information

  • Patent Grant
  • 4113964
  • Patent Number
    4,113,964
  • Date Filed
    Monday, August 1, 1977
    47 years ago
  • Date Issued
    Tuesday, September 12, 1978
    46 years ago
Information
Abstract
This invention comprises certain analogs of the prostaglandins in which the double bond between C-13 and C-14 is replaced by a triple bond. Also provided in this invention, are novel chemical processes and novel chemical intermediates useful in the preparation of the above prostaglandin analogs. These prostaglandin analogs exhibit prostaglandin-like activity, and are accordingly useful for the same pharmacological purposes as the prostaglandins. Among these purposes are blood pressure lowering, labor induction at term, reproductive-cycle regulation, gastric antisecretory action, and the like.
Description
Claims
  • 1. A prostaglandin analog of the formula ##STR1## wherein ##STR2## wherein Z.sub.4 is --(CH.sub.2).sub.3 --(CH.sub.2).sub.g --CH.sub.2 -- or --(CH.sub.2).sub.3 --(CH.sub.2).sub.g --CF.sub.2 --; wherein g is one, 2, or 3; wherein R.sub.7 is ##STR3## WHEREIN Z.sub.3 is oxa or methylene, s is zero, one, 2, or 3, and T is chloro, fluoro, trifluoromethyl, alkyl of one to 3 carbon atoms, inclusive, or alkoxy of one to 3 carbon atoms, inclusive, the various T's being the same or different, with the proviso that not more than two T's are other than alkyl; wherein L.sub.1 is ##STR4## or a mixture of ##STR5## wherein R.sub.3 and R.sub.4 are hydrogen, methyl, or fluoro, being the same or different with the proviso that one of R.sub.3 and R.sub.4 is methyl only when the other is hydrogen or methyl, with the further proviso that one or both of R.sub.3 and R.sub.4 is fluoro only when Z.sub.3 is methylene; wherein M.sub.1 is ##STR6## wherein R.sub.5 and R.sub.6 are hydrogen or methyl, with the proviso that one of R.sub.5 and R.sub.6 is methyl only when the other is hydrogen; and wherein R.sub.1 is hydrogen, alkyl of one to 12 carbon atoms, inclusive, cycloalkyl of 3 to 10 carbon atoms, inclusive, aralkyl of 7 to 12 carbon atoms, inclusive, phenyl, phenyl substituted with one, two, or three chloro or alkyl of one to 3 carbon atoms, inclusive, or a pharmacologically acceptable cation.
  • 2. A compound according to claim 1, wherein ##STR7##
  • 3. A compound according to claim 2, wherein M.sub.1 is ##STR8##
  • 4. A compound according to claim 3, wherein g is one.
  • 5. A compound according to claim 4, wherein R.sub.3, R.sub.4, R.sub.5, and R.sub.6 are all hydrogen.
  • 6. 15-epi-13,14-Didehydro-8.beta.,12.alpha.-11-deoxy-17-phenyl-18,19,20-trinor-PGF.sub.1 .alpha., methyl ester, a compound according to claim 4.
  • 7. A compound according to claim 2, wherein M.sub.1 is ##STR9##
  • 8. A compound according to claim 7, wherein g is three.
  • 9. A compound according to claim 7, wherein g is one.
  • 10. A compound according to claim 9, wherein R.sub.3 and R.sub.4 are both hydrogen.
  • 11. A compound according to claim 10, wherein R.sub.5 is methyl.
  • 12. 15-Methyl-13,14-didehydro-8.beta.,12.alpha.-11-deoxy-17-phenyl-18,19,20-trinor-PGF.sub.1 .alpha., a compound according to claim 11.
  • 13. 15-Methyl-13,14-didehydro-8.beta.,12.alpha.-11-deoxy-17-phenyl-18,19,20-trinor-PGF.sub.1 .alpha., methyl ester, a compound according to claim 11.
  • 14. A compound according to claim 10, wherein R.sub.6 is methyl.
  • 15. 13,14-Didehydro-8.beta.,12.alpha.-11-deoxy-17-phenyl-18,19,20-trinor-PGF.sub.1 .alpha., 15-methyl ether, a compound according to claim 14.
  • 16.13,14-Didehydro-8.beta.,12.alpha.-11-deoxy-17-phenyl-18,19,20-trinor-PGF.sub.1 .alpha., methyl ester, 15-methyl ether, a compound according to claim 14.
  • 17. A compound according to claim 10, wherein R.sub.5 and R.sub.6 are both hydrogen.
  • 18. 13,14-Didehydro-8.beta.,12.alpha.-11-deoxy-17-phenyl-18,19,20-trinor-PGF.sub.1 .alpha., a compound according to claim 17.
  • 19. 13,14-Didehydro-8.beta.,12.alpha.-11-deoxy-17-phenyl-18,19,20-trinor-PGF.sub.1 .alpha., methyl ester, a compound according to claim 17.
  • 20. A compound according to claim 9, wherein at least one of R.sub.3 and R.sub.4 is methyl.
  • 21. A compound according to claim 20, wherein R.sub.3 and R.sub.4 are both methyl.
  • 22. A compound according to claim 21, wherein R.sub.5 is methyl.
  • 23. 15,16,16-Trimethyl-13,14-didehydro-8.beta.,12.alpha.-11-deoxy-17-phenyl-18,19,20-trinor-PGF.sub.1 .alpha., methyl ester, a compound according to claim 22.
  • 24. A compound according to claim 21, wherein R.sub.6 is methyl.
  • 25. 16,16-Dimethyl-13,14-didehydro-8.beta.,12.alpha.-11-deoxy-17-phenyl-18,19,20-trinor-PGF.sub.1 .alpha., methyl ester, 15-methyl ether, a compound according to claim 24.
  • 26. A compound according to claim 21, wherein R.sub.5 and R.sub.6 are both hydrogen.
  • 27. 16,16-Dimethyl-13,14-didehydro-8.beta.,12.alpha.-11-deoxy-17-phenyl-18,19,20-trinor-PGF.sub.1 .alpha., a compound according to claim 26.
  • 28. 16,16-Dimethyl-13,14-didehydro-8.beta.,12.alpha.-11-deoxy-17-phenyl-18,19,20-trinor-PGF.sub.1 .alpha., methyl ester, a compound according to claim 26.
  • 29. A compound according to claim 9, wherein at least one of R.sub.3 and R.sub.4 is fluoro.
  • 30. A compound according to claim 29, wherein R.sub.3 and R.sub.4 are both fluoro.
  • 31. A compound according to claim 30, wherein R.sub.5 is methyl.
  • 32. 15-Methyl-16,16-difluoro-13,14-didehydro-8.beta.,12.alpha.-11-deoxy-17-phenyl-18,19,20-trinor-PGF.sub.1 .alpha., methyl ester, a compound according to claim 31.
  • 33. A compound according to claim 30, wherein R.sub.6 is methyl.
  • 34. 16,16-Difluoro-13,14-didehydro-8.beta.,12.alpha.-11-deoxy-17-phenyl-18,19,20-trinor-PGF.sub.1 .alpha., methyl ester, 15-methyl ether, a compound according to claim 33.
  • 35. A compound according to claim 30, wherein R.sub.5 and R.sub.6 are both hydrogen.
  • 36. 16,16-Difluoro-13,14-didehydro-8.beta.,12.alpha.-11-deoxy-17-phenyl-18,19,20-trinor-PGF.sub.1 .alpha., methyl ester, a compound according to claim 35.
  • 37. 16,16-Difluoro-13,14-didehydro-8.beta.,12.alpha.-11-deoxy-17-phenyl-18,19,20-trinor-PGF.sub.1 .alpha., methyl ester, a compound according to claim 35.
  • 38. A compound according to claim 1, wherein ##STR10##
  • 39. A compound according to claim 38, wherein M.sub.1 is ##STR11##
  • 40. A compound according to claim 39, wherein g is one.
  • 41. A compound according to claim 40, wherein R.sub.3, R.sub.4, R.sub.5, and R.sub.6 are all hydrogen.
  • 42. 13,14-Didehydro-11-deoxy-17-phenyl-18,19,20-trinor-PGF.sub.1 .alpha., methyl ester, a compound according to claim 41.
  • 43. A compound according to claim 38, wherein M.sub.1 is ##STR12##
  • 44. A compound according to claim 43, wherein g is three.
  • 45. A compound according to claim 43, wherein g is one.
  • 46. A compound according to claim 45, wherein R.sub.3 and R.sub.4 are both hydrogen.
  • 47. A compound according to claim 46, wherein R.sub.5 is methyl.
  • 48. 15-Methyl-13,14-didehydro-11-deoxy-17-phenyl-18,19,20-trinor-PGF.sub.1 .alpha., a compound according to claim 47.
  • 49. 15-Methyl-13,14-didehydro-11-deoxy-17-phenyl-18,19,20-trinor-PGF.sub.1 .alpha., methyl ester, a compound according to claim 47.
  • 50. A compound according to claim 46, wherein R.sub.6 is methyl.
  • 51. 13,14-Didehydro-11-deoxy-17-phenyl-18,19,20-trinor-PGF.sub.1 .alpha., 15-methyl ether, a compound according to claim 50.
  • 52. 13,14-Didehydro-11-deoxy-17-phenyl-18,19,20-trinor-PGF.sub.1 .alpha., methyl ester, 15-methyl ether, a compound according to claim 50.
  • 53. A compound according to claim 46, wherein R.sub.5 and R.sub.6 are both hydrogen.
  • 54. 13,14-Didehydro-11-deoxy-17-phenyl-18,19,20-trinor-PGF.sub.1 .alpha., a compound according to claim 53.
  • 55. 13,14-Didehydro-11-deoxy-17-phenyl-18,19,20-trinor-PGF.sub.1 .alpha., methyl ester, a compound according to claim 53.
  • 56. A compound according to claim 45, wherein at least one of R.sub.3 and R.sub.4 is methyl.
  • 57. A compound according to claim 56, wherein R.sub.3 and R.sub.4 are both methyl.
  • 58. A compound according to claim 57, wherein R.sub.5 is methyl.
  • 59. 15,16,16-Trimethyl-13,14-didehydro-11-deoxy-17-phenyl-18,19,20-trinor-PGF.sub.1 .alpha., methyl ester, a compound according to claim 58.
  • 60. A compound according to claim 57, wherein R.sub.6 is methyl.
  • 61. 16,16-Dimethyl-13,14-didehydro-11-deoxy-17-phenyl-18,19,20-trinor-PGF.sub.1 .alpha., methyl ester, 15-methyl ether, a compound according to claim 60.
  • 62. A compound according to claim 57, wherein R.sub.5 and R.sub.6 are both hydrogen.
  • 63. 16,16-Dimethyl-13,14-didehydro-11-deoxy-17-phenyl-18,19,20-trinor-PGF.sub.1 .alpha., a compound according to claim 62.
  • 64. 16,16-Dimethyl-13,14-didehydro-11-deoxy-17-phenyl-18,19,20-trinor-PGF.sub.1 .alpha., methyl ester, a compound according to claim 62.
  • 65. A compound according to claim 45, wherein at least one of R.sub.3 and R.sub.4 is fluoro.
  • 66. A compound according to claim 65, wherein R.sub.3 and R.sub.4 are both fluoro.
  • 67. A compound according to claim 66, wherein R.sub.5 is methyl.
  • 68. 15-Methyl-16,16-difluoro-13,14-didehydro-11-deoxy-17-phenyl-18,19,20-trinor-PGF.sub.1 .alpha., methyl ester, a compound according to claim 67.
  • 69. A compound according to claim 66, wherein R.sub.6 is methyl.
  • 70. 16,16-Difluoro-13,14-didehydro-11-deoxy-17-phenyl-18,19,20-trinor-PGF.sub.1 .alpha., methyl ester, 15-methyl ether, a compound according to claim 69.
  • 71. A compound according to claim 66, wherein R.sub.5 and R.sub.6 are both hydrogen.
  • 72. 16,16-Difluoro-13,14-didehydro-11-deoxy-17-phenyl-18,19,20-trinor-PGF.sub.1 .alpha., a compound according to claim 71.
  • 73. 16,16-Difluoro-13,14-didehydro-11-deoxy-17-phenyl-18,19,20-trinor-PGF.sub.1 .alpha., methyl ester, a compound according to claim 71.
Parent Case Info

The present application is a divisional application of Ser. No. 657,740, filed Feb. 13, 1976, now pending issuance as a U.S. Patent.

Non-Patent Literature Citations (5)
Entry
derwent Abstract 4723U-B DT 2305044Q (Sep. 7, 1973).
Derwent Abstract 18176y/11 BE 846-080 (Oct. 7, 1977).
Derwent Abstract 61891x/33 DT 2603-172 (May 8, 1976).
Derwent Abstract 59715x/32 BE 839-533 (Jan. 7, 1976).
Derwent Abstract 79219x/42 U.S. 3,984,400 (May 1, 1976).
Divisions (1)
Number Date Country
Parent 657740 Feb 1976